Fig. 3From: EGFR plasma mutation in prediction models for resistance with EGFR TKI and survival of non-small cell lung cancerProgression-free survival between groups: new metastasis site (a£, bǂ). £: all patients; ǂ: the newly diagnosed groupBack to article page